We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Review · August 12, 2021

DOACs vs VKAs in Patients With Antiphospholipid Syndrome

RMD Open


Additional Info

RMD Open
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: Systematic Review and Meta-Analysis
RMD Open 2021 Jul 01;7(2)0, N Koval, M Alves, R Plácido, AG Almeida, JE Fonseca, JJ Ferreira, FJ Pinto, D Caldeira

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading